SI1716128T1 - Substituirane 4,5,6,7-tetrahidro-benzotiazol-2-ilaminske spojine - Google Patents
Substituirane 4,5,6,7-tetrahidro-benzotiazol-2-ilaminske spojineInfo
- Publication number
- SI1716128T1 SI1716128T1 SI200531043T SI200531043T SI1716128T1 SI 1716128 T1 SI1716128 T1 SI 1716128T1 SI 200531043 T SI200531043 T SI 200531043T SI 200531043 T SI200531043 T SI 200531043T SI 1716128 T1 SI1716128 T1 SI 1716128T1
- Authority
- SI
- Slovenia
- Prior art keywords
- substituted
- benzothiazol
- tetrahydro
- ylamine compounds
- ylamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004006808A DE102004006808A1 (de) | 2004-02-11 | 2004-02-11 | Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen |
| EP05715296A EP1716128B1 (de) | 2004-02-11 | 2005-02-11 | Substituierte 4,5,6,7-tetrahydro-benzothiazol-2-ylamin-verbindungen |
| PCT/EP2005/001369 WO2005077924A1 (de) | 2004-02-11 | 2005-02-11 | Substituierte 4,5,6,7-tetrahydro-benzothiazol-2-ylamin-verbindungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1716128T1 true SI1716128T1 (sl) | 2010-08-31 |
Family
ID=34813281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200531043T SI1716128T1 (sl) | 2004-02-11 | 2005-02-11 | Substituirane 4,5,6,7-tetrahidro-benzotiazol-2-ilaminske spojine |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7348347B2 (sl) |
| EP (1) | EP1716128B1 (sl) |
| JP (1) | JP5016312B2 (sl) |
| AT (1) | ATE462699T1 (sl) |
| CA (1) | CA2555595C (sl) |
| CY (1) | CY1110156T1 (sl) |
| DE (2) | DE102004006808A1 (sl) |
| DK (1) | DK1716128T3 (sl) |
| ES (1) | ES2343735T3 (sl) |
| PL (1) | PL1716128T3 (sl) |
| PT (1) | PT1716128E (sl) |
| SI (1) | SI1716128T1 (sl) |
| WO (1) | WO2005077924A1 (sl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1637529A1 (en) | 2004-09-20 | 2006-03-22 | 4Sc Ag | Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of T-cell proliferation and uses thereof |
| US7601745B2 (en) | 2004-09-27 | 2009-10-13 | 4Sc Ag | Heterocyclic NF-kB inhibitors |
| GB0712101D0 (en) * | 2007-06-22 | 2007-08-01 | Therapeutics Ltd E | Treatment of depression |
| GB0811024D0 (en) * | 2008-06-17 | 2008-07-23 | E Therapeutics Plc | Sustained release treatment of depression |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3447075A1 (de) * | 1984-12-22 | 1986-07-03 | Dr. Karl Thomae Gmbh, 7950 Biberach | Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arzneimittel |
| EP0186087B1 (de) * | 1984-12-22 | 1989-08-23 | Dr. Karl Thomae GmbH | Tetrahydro-benzthiazole, deren Herstellung und deren Verwendung als Zwischenprodukte oder als Arnzneimittel |
| FR2658823B1 (fr) * | 1990-02-27 | 1992-04-30 | Adir | Nouveaux derives d'aminomethylpiperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent . |
| FR2681325B1 (fr) * | 1991-09-16 | 1993-12-17 | Fabre Medicament Pierre | Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique. |
| DE4241013A1 (de) * | 1992-12-05 | 1994-06-09 | Boehringer Ingelheim Kg | Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung |
| US5712270A (en) * | 1995-11-06 | 1998-01-27 | American Home Products Corporation | 2-arylamidothiazole derivatives with CNS activity |
| TR200001312T2 (tr) * | 1997-11-10 | 2000-09-21 | Bristol-Myers Squibb Company | Benzotiyazol protein tirozin kinaz önleyicileri. |
| EP1242072A4 (en) * | 1999-12-17 | 2004-02-04 | Bristol Myers Squibb Co | ANTIPSYCHOTIC HETEROCYCLIC COMPOUNDS |
| GB0114185D0 (en) * | 2001-06-12 | 2001-08-01 | Protherics Molecular Design Lt | Compounds |
-
2004
- 2004-02-11 DE DE102004006808A patent/DE102004006808A1/de not_active Withdrawn
-
2005
- 2005-02-11 DK DK05715296.9T patent/DK1716128T3/da active
- 2005-02-11 SI SI200531043T patent/SI1716128T1/sl unknown
- 2005-02-11 JP JP2006552551A patent/JP5016312B2/ja not_active Expired - Fee Related
- 2005-02-11 ES ES05715296T patent/ES2343735T3/es active Active
- 2005-02-11 EP EP05715296A patent/EP1716128B1/de active Active
- 2005-02-11 CA CA2555595A patent/CA2555595C/en not_active Expired - Fee Related
- 2005-02-11 WO PCT/EP2005/001369 patent/WO2005077924A1/de active Application Filing
- 2005-02-11 PL PL05715296T patent/PL1716128T3/pl unknown
- 2005-02-11 DE DE502005009310T patent/DE502005009310D1/de active Active
- 2005-02-11 AT AT05715296T patent/ATE462699T1/de active
- 2005-02-11 PT PT05715296T patent/PT1716128E/pt unknown
-
2006
- 2006-08-11 US US11/502,456 patent/US7348347B2/en not_active Expired - Fee Related
-
2010
- 2010-06-25 CY CY20101100582T patent/CY1110156T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2555595C (en) | 2013-10-29 |
| US7348347B2 (en) | 2008-03-25 |
| JP2007522171A (ja) | 2007-08-09 |
| PT1716128E (pt) | 2010-07-06 |
| CA2555595A1 (en) | 2005-08-25 |
| DE102004006808A1 (de) | 2005-09-01 |
| EP1716128B1 (de) | 2010-03-31 |
| EP1716128A1 (de) | 2006-11-02 |
| ATE462699T1 (de) | 2010-04-15 |
| DE502005009310D1 (de) | 2010-05-12 |
| JP5016312B2 (ja) | 2012-09-05 |
| CY1110156T1 (el) | 2015-01-14 |
| ES2343735T3 (es) | 2010-08-09 |
| WO2005077924A1 (de) | 2005-08-25 |
| PL1716128T3 (pl) | 2010-09-30 |
| DK1716128T3 (da) | 2010-07-26 |
| US20070027315A1 (en) | 2007-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200604179A (en) | Pyrazole derivatives, compositions containing such compounds and methods of use | |
| PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
| ATE414089T1 (de) | Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust | |
| DE602004021472D1 (en) | Pyrimiidinverbindungen | |
| WO2007014372A3 (en) | Compositions and methods for treating bacteria | |
| SE0200920D0 (sv) | Novel compounds | |
| MXPA04006280A (es) | Compuestos espiroazaciclicos como moduladores de receptor de monoamina. | |
| TW200510334A (en) | Preraration and use of aryl alkyl acid derivatives for the treatment of obesity | |
| IL206009A (en) | Methods for identifying and selecting inhibitors of pyroglutamic acid formation | |
| MXPA05010712A (es) | Derivados de quinolin-2-ona para el tratamiento de enfermedades de las vias respiratorias. | |
| EP1765335A4 (en) | PYRAZOLAMIDE DERIVATIVES, COMPOSITIONS AND METHODS OF APPLYING THESE COMPOUNDS | |
| HK1092467A1 (en) | N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n- | |
| DE502005008058D1 (de) | Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen | |
| TW200738659A (en) | Novel compounds | |
| DE502005005636D1 (en) | Spirocyclische cyclohexan-derivate | |
| TW200745044A (en) | Pyrazole derivatives, compositions containing such compounds and methods of use | |
| ATE457027T1 (de) | Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht | |
| DE60112766D1 (de) | Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen | |
| MX2009003981A (es) | Agentes moduladores del receptor de calcio. | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| UA90504C2 (ru) | Лекарственное средство для лечения заболеваний дыхательных путей | |
| BRPI0415164A (pt) | dispositivo para administrar uma composição bioterapêutica, composição bioterapêutica, método de preparação de uma composição bioterapêutica, método de tratamento, e dispensador | |
| ATE554753T1 (de) | 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia | |
| WO2004073615A3 (en) | Deazaflavin compounds and methods of use thereof | |
| CY1110156T1 (el) | Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης |